40 results
424B5
STOK
Stoke Therapeutics Inc
28 Mar 24
Prospectus supplement for primary offering
5:15pm
federal government shutdown, on our business, financial condition and operations, including on our expenses, supply chain, strategic partners, research
424B5
STOK
Stoke Therapeutics Inc
26 Mar 24
Prospectus supplement for primary offering
4:47pm
, financial condition and operations, including on our expenses, supply chain, strategic partners, research and development costs, clinical trials and employees
8-K
EX-99.1
t3b mhuizt
10 Jan 22
Entry into a Material Definitive Agreement
7:01am
8-K
EX-99.1
txihnmzkfz42aarm9e5l
10 May 21
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
7:05am
8-K
EX-99.1
gcxrrf dex05z0e3o
9 Mar 21
Stoke Therapeutics Reports Full Year 2020 Financial Results and Provides Business Updates
7:30am
8-K
EX-99.1
5ey8olubowc5q7
5 Feb 21
Regulation FD Disclosure
4:27pm